Ji-Hyun Lee

Dr. Ji-Hyun Lee

Cell and Gene Therapy Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
HKHyeon Soo Kim
Hyeon Soo Kim
SPSun Young Park
Sun Young Park
KSKoei Shinzawa
Koei Shinzawa
SKSunshin Kim
Sunshin Kim
KCKun Wook Chung
Kun Wook Chung
MLMyung-Shik Lee
Myung-Shik Lee
The pathogenesis of nonalcoholic steatohepatitis (NASH) is unclear, despite epidemiological data implicating FFAs. We studied the pathogenesis of NASH using lipoapoptosis models. Palmitic acid (PA) induced classical apoptosis of hepatocytes. PA-induced lipoapoptosis was inhibited by acyl-CoA synthetase inhibitor but not by ceramide synthesis inhibitors, suggesting that conversion products other than ceramide are involved. Phospholipase A2 (PLA2) inhibitors blocked PA-induced hepatocyte death, suggesting an important role for PLA2 and its product lysophosphatidylcholine (LPC). Small interfering RNA for Ca2+-independent phospholipase A2 (iPLA2) inhibited the lipoapoptosis of hepatocytes. PA increased LPC content, which was reversed by iPLA2 inhibitors. Pertussis toxin or dominant-negative Gαi mutant inhibited hepatocyte death by PA or LPC acting through G-protein-coupled receptor (GPCR)/Gαi. PA decreased cardiolipin content and induced mitochondrial potential loss and cytochrome c translocation. Oleic acid inhibited PA-induced hepatocyte death by diverting PA to triglyceride and decreasing LPC content, suggesting that FFAs lead to steatosis or lipoapoptosis according to the abundance of saturated/unsaturated FFAs. LPC administration induced hepatitis in vivo. LPC content was increased in the liver specimens from NASH patients. These results demonstrate that LPC is a death effector in the lipoapoptosis of hepatocytes and suggest potential therapeutic values of PLA2 inhibitors or GPCR/Gαi inhibitors in NASH.

1 July 2007 in Cell Transplantation
Verified
Journal Article
Open access
KLKwang-Woong Lee
Kwang-Woong Lee
Ji-Hyun LeeJi-Hyun Lee
Ji-Hyun Lee
SSSung Wook Shin
Sung Wook Shin
SKSung Joo Kim
Sung Joo Kim
JJJae-Won Joh
Jae-Won Joh
SLSuk-Koo Lee
Suk-Koo Lee
Glycogen storage disease type I (GSD-I) is a group of autosomal recessive disorders with an incidence of 1 in 100,000. The two major subtypes are GSD-Ia, caused by a deficiency of glucose-6-phosphatase (G6Pase), and GSD-Ib, caused by a deficiency of glucose-6-phosphate transporter (G6PT). We report that a substantial improvement was achieved following several infusions of hepatocytes in a patient with GSD-Ib. Hepatocytes were isolated from the unused cadaveric whole livers of two donors. At the first transplantation, approximately 2 × 109 cells (2% of the estimated recipient's total hepatocytes) were infused. Seven days later 1 × 109 (1% of liver mass) cryopreserved hepatocytes from the same donor were infused, and an additional 3 × 109 (3% of liver mass) cells from the second donor were infused 1 month after the second transplantation. After the hepatocyte transplantation, the patient showed no hypoglycemic symptoms despite the discontinuation of cornstarch meals. Liver biopsies on posttransplantation days 20 and 250 showed a normal level of glucose-6-phosphatase activity in presolubilization assay that was very low before transplantation. This was the first and successful clinical hepatocyte transplantation in Korea. In this study, hepatocyte transplantation allowed a normal diet in a patient with GSD-Ib, with substantial improvement in their quality of life. Hepatocyte transplantation might be an alternative to liver transplantation and dietary therapy in GSD-Ib.

1 October 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
KLK.W. Lee
K.W. Lee
JYJ.J. Yoon
J.J. Yoon
Ji-Hyun LeeJi-Hyun Lee
Ji-Hyun Lee
SKS.Y. Kim
S.Y. Kim
HJH.J. Jung
H.J. Jung
SLS.K. Lee
S.K. Lee

1 May 2001 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
Ji-Hyun LeeJi-Hyun Lee
Ji-Hyun Lee
JKJeong-Hwa Kim
Jeong-Hwa Kim
IZIl-Hui Zhu
Il-Hui Zhu
XZXiao-Bei Zhan
Xiao-Bei Zhan
JLJin-Woo Lee
Jin-Woo Lee
SKSung-Koo Kim
Sung-Koo Kim

1 February 2016 in Journal of Hepatology
Verified
Journal Article
Closed access
YPYong Kwang Park
Yong Kwang Park
EPEun-Sook Park
Eun-Sook Park
DKDoo Hyun Kim
Doo Hyun Kim
SASung Hyun Ahn
Sung Hyun Ahn
SPSeung Hwa Park
Seung Hwa Park
KKKyun-Hwan Kim
Kyun-Hwan Kim

1 June 2000 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
JKJeong-Hwa Kim
Jeong-Hwa Kim
MKMi-Ryung Kim
Mi-Ryung Kim
Ji-Hyun LeeJi-Hyun Lee
Ji-Hyun Lee
JLJin-Woo Lee
Jin-Woo Lee
SKSung-Koo Kim
Sung-Koo Kim